article thumbnail

Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development

BioTech 365

Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development – Shorrock Rejoins Company; Appointment Underscores Company’s Pursuit of Commercial … Continue reading →

article thumbnail

Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari – Xtalks Life Science Podcast Ep. 146

XTalks

Abid Ansari, MBA Chief Financial Officer OncoC4 Abid Ansari is a finance executive with a more 20-year track record in the life sciences industry encompassing corporate finance, fundraising, business development and investor relations experiences for public and private life science companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

The payload, Del Bourgo tell us, is the therapeutic DNA or RNA sequence that will cure or fix damaged cells. Now, we can grow our R&D more rapidly and hire more business development and marketing colleagues to extend our reach to customers,” Del Bourgo says. “This is just the beginning; the potential is enormous,” he says.

Genomics 105
article thumbnail

CureLab Oncology Establishes Operations in the Gulf Region

The Pharma Data

CureLab’s partners in the region will test the efficacy of the company’s DNA-based products against cancers and non-cancerous diseases of chronic inflammation. CureLab has appointed Jihad Fakhreddine as director of business development, representing CureLab in the region. BOSTON , Oct.

DNA 52
article thumbnail

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 billion) mark. Chief technology officer Clive Brown is also sitting on a £10 million stake.

article thumbnail

Seqster launches new cloud version of virtual trial data tool

pharmaphorum

service will allow secure access to real-world data from electronic health records (EHRs), DNA analysis and fitness wearables. However, the company’s head of strategic business development Parsi Parsinejad said that the system is differentiated from competitors by its focus on putting patients in control of their data.

Trials 52
article thumbnail

[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity

The Pharma Data

Haydn Boehm is the Head of Commercial Marketing for Merck’s Connected Lab digital program and has over 20 years’ experience in marketing and business development within the life scientific sector. Dr. Pepe has a PhD in cancer biology and DNA repair and extensive experience in development and validation of cell-based assays.